Relay Therapeutics AI case studies

Explore 1 documented AI medicine implementation at Relay Therapeutics. These source-extracted records passed the automated evidence gate; that is not independent fact verification.

Pharmaceutical & Life Science · MidMarket · 1 AI implementation

Relay Therapeutics has 1 documented AI medicine implementation covering workflows including Drug Discovery & Development and technology including Machine Learning & Predictive Analytics. The records below separate source-reported results from evidence the source did not provide.

Based on 1 documented implementationsCorpus published through Mar 28, 2026Source links checked through Jul 28, 2026

Maintained by Peter Korpak, Founder & Chief AnalystHow evidence is checked

Case Studies

Use Case Types

Technologies

AI implementations at Relay Therapeutics

Relay Therapeutics

Relay Therapeutics AI platform drives 81% tumor reduction in breast cancer Phase 3 trial

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentMachine Learning & Predictive Analytics

Reported result:: 81% of participants Tumor Size Reduction Rate
Deployment timeframe:: Not reported by source
Technology:: Machine Learning & Predictive Analytics
Vendor:: Not available in record

Cited source: cen.acs.orgSource link checked Jul 28, 2026Automated evidence gate passed

More in Pharmaceutical & Life Science

Bristol Myers Squibb5 Insilico Medicine5 AstraZeneca3 Pfizer3 Merck & Co.1 Sumitomo Dainippon Pharma1 Leading Global Biopharma Company1 Sanofi1 Bayer1 Merck1